Rate My Professor Rosy Krajmalnik-Brown

Krajmalnik-Brown’s research specializes in environmental biotechnology, microbial ecology, and the human gut microbiome. She investigates microbial communities for bioenergy production, toxic compound degradation, and their roles in obesity, metabolism, autism spectrum disorders, and gut-brain interactions. Notable contributions include collaborations on microbiota transfer therapy, demonstrating long-term improvements in gastrointestinal symptoms and autism behaviors in children, as detailed in key publications such as “Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms” (2017) and “Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota” (2019). She has authored over 130 peer-reviewed articles, holds more than 40 issued patents, and cofounded Gut-Brain-Axis Therapeutics Inc. Awards include the NSF CAREER Award (2011), Phoenix Business Journal’s “40 under 40” recognition, the Distinguished Alumni Award from Universidad Autónoma Metropolitana (2019), and election as a fellow of the National Academy of Inventors. Her work has advanced diagnostic methods for autism via blood and urine samples and fostered interdisciplinary microbiome research impacting health and environmental solutions.